Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (68)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vallat, J. M.
Right arrow Articles by Vallat, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallat, J. M.
Right arrow Articles by Vallat, A. V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 118, No. 5, 1233-1245, 1995
© 1995 Guarantors of Brain

research-article

Non-Hodgkin malignant lymphomas and peripheral neuropathies—13 cases

J. M. Vallat, H. A. De Mascarel, D. Bordessoule, M. O. Jauberteau, F. Tabaraud, A. Gelot and A. V. Vallat

Department of Neurology, University Hospital Limoges, France

Correspondence to: J. M. Vallat, Department of Neurology, University Hospital, 2 Av. Martin Luther King, 87042 Limoges Cedex, France

Non-Hodgkin's malignant lymphomas (NHML) are malignant lymphoid proliferations which may be of B or T cell type. Thirteen observations of an association between peripheral neuropathy and B type NHML are reported. None of the cases had evidence of meningeal propagation or neurotoxicity from chemotherapy. The NHML were classified according to the Working Formulation and Kiel classifications. The various mechanisms of peripheral neuropathy in these cases were split into four broad groups. Group I consisted of four cases in which the peripheral nerve lesions were directly linked to a propagation of malignant cells into the peripheral nervous system; this was revealed by autopsy and/or nerve biopsy. Malignant B cell proliferation was demonstrated in three out of four of these cases by immunolabelling of the infiltrates. Group II included three patients whose serum contained a monoclonal immunoglobulin (IgM) with antimyelin activity, and two who had pathological IgM deposits in endoneurial connective tissue. Group III comprised two cases. The immune dysfunction of the NHML was responsible for a Guillain-Barre syndrome in one, and for a chronic inflammatory demyelinating polyneuropathy in the other. Group IV included two patients in whom the mechanism of the peripheral neuropathy, although almost certainly directly related to the NHML, could not be determined beyond doubt. The peripheral neuropathy might have been a result of a paraneoplasic process or, possibly, an undetected lymphomatous invasion of nervous tissue. All these cases of clinically diverse peripheral neuropathy, which either occurred before the discovery of the haemopathy or arose as complications of it, are discussed along with similar observations reported in the literature. Immunolabelling of lymphomatous proliferations and nerves is now of considerable value for classifying and indicating the exact aetiology of the peripheral neuropathy. It can also detect pathogenic consequences of any associated monoclonal dysglobulinemia. In any event, a direct link between the peripheral neuropathy and NHML represents an indication for intensification of specific chemotherapy, which in some of our patients led to significant regression of the peripheral neuropathy. Nonetheless, in some cases, the link between peripheral neuropathy and NHML could not be established with certainty. Long-term follow-up is essential in such cases. The present results show the importance of a case by case study of patients with NHML and peripheral neuropathy.

non-Hodgkin malignant lymphoma; peripheral nerve; Peripheral neuropathy; nerve biopsy

Received March 21, 1995. Accepted April 14, 1995.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
K Viala, A Behin, T Maisonobe, J-M Leger, T Stojkovic, F Davi, V Leblond, and P Bouche
Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis?
J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 778 - 782.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. Riva, G. Bezzi, M. Ponzoni, R. Epis, S. C. Previtali, F. Cerri, R. Nemni, G. Comi, and A. Quattrini
LYMPHOMATOUS NEUROPATHY IN COLD AGGLUTININ DISEASE
Neurology, May 6, 2008; 70(19): 1715 - 1716.
[Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A J Wills, S O'Connor, and A McMillan
Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 484 - 485.
[Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
J. M. Baehring, D. Damek, E. C. Martin, R. A. Betensky, and F. H. Hochberg
Neurolymphomatosis
Neuro-oncol, April 1, 2003; 5(2): 104 - 115.
[Abstract] [PDF]

Home page
 NeuroscientistHome page
J. O. Dalmau and J. B. Posner
Neurological Paraneoplastic Syndromes
Neuroscientist, November 1, 1998; 4(6): 443 - 453.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.